Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9335221 | Reproductive BioMedicine Online | 2005 | 10 Pages |
Abstract
Cell transplantation is being discussed as a potential therapy for multiple disorders caused by loss or malfunction of single or at most a few cell types. These include diabetes, Parkinson's disease and myocardial infarction or cardiac failure. However, it is not yet clear whether cells from adult tissues ('adult stem cells') or embryos ('embryonic stem cells') will prove to be the most appropriate replacement cells; most likely, each disease will have its own preferred source. This study presents the background to this discussion and the current state of research in replacement of cardiac tissue, with focus on recent developments using human embryonic stem cells. It also describes a new human embryonic stem cell (HESC) line, NL-HESC1, the first to be derived in the Netherlands, and shows that it forms cardiac cells in a manner comparable with that of hES2 and hES3 cells grown in the same laboratory.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Anja van de Stolpe, Stieneke van den Brink, Marga van Rooijen, Dorien Ward-van Oostwaard, Wouter van Inzen, Ineke Slaper-Cortenbach, Bart Fauser, Nijske van den Hout, Sjerp Weima, Robert Passier, Nigel Smith, Chris Denning, Christine Mummery,